Interestingly, EPHA2 expression is upregulated during AMP-activated protein kinase (AMPK)-dependent metabolic cancer cell reprogramming and co-expression of AMPK and EPHA2 in CRC tumors is correlated with higher CD3+ T cell infiltration [19]. The gene discussed is EPHA2; the disease is cancer.